Archive: jae bang


Startup Insider: Medtech Portfolio Company Changes Name

By Early Investing on February 7, 2022

Heart failure is a massive health problem in the U.S. More than 6 million Americans have it. And it’s one of the most expensive health problems for patients to manage.  Early detection is the key for effective treatment. But no company has been able to provide an affordable and powerful medical device to tackle early detection… except for Future Cardia, that is. Future Cardia (previously known as Oracle Health) has developed a tiny implant…
Andy Gordon first recommended Oracle Health to First Stage Investor members in February. The company is developing a long-term insertable cardiac monitor for heart failure.  Oracle has ambitious — but achievable — plans to get FDA clearance…